Edibles available in smaller doses of marijuana are gaining interest among consumers. Annually, the national marijuana market generates $5.4 billion in ...
October, 2016
-
19 October
Civil Rights Groups Call for U.S. to Decriminalize Personal Drug Use
The American Civil Liberties Union (ACLU) and Human Rights Watch are both calling for decriminalization of all drugs for personal use. ...
-
19 October
Legal Marijuana Free of Problems That Opponents Claimed it Would Cause
It was controversial when both Colorado and Washington legalized recreational marijuana in 2012. Those opposing legalization sent warnings that ending prohibition ...
-
18 October
Jamaica Looks to Cash in on Medical Marijuana as “Wellness Tourism”
Jamaican leaders have sensed opportunity and want to cash in on the reputation it has for being the “land of ganja.” ...
-
18 October
Researchers Discover That THC Makes People Smarter
For as long as anyone can remember there’s been a stigma about marijuana users and lack of intelligence. But scientific evidence ...
-
14 October
The United Kingdom Declares that Cannabidiol (CBD) is Medicine
Cannabidiol (CBD), one of the non-psychoactive components found in marijuana, has been declared as medicine by the UK’s Medicines and Healthcare ...
-
14 October
A Quickly Budding Trend: Medical Marijuana for Pets
A 12-year old arthritic cat’s owner, Lisa Mastramico, wanted a better option for relieving her cat’s pain. She turned to marijuana ...
-
12 October
Marijuana Legalization Would Demolish Drug Cartels’ Smuggling
Along the U.S./Mexico border, parts of the wall are only a few feet high, making it easy for cartels to smuggle ...
-
12 October
Company’s Stock Jumps to Epic High from Snoop Dogg Partnership
Earlier this year, Snoop Dogg announced his partnership with Canopy Growth Corp., a publicly-traded Canadian marijuana company. Since then, the stock’s ...
-
10 October
DEA Reduces United States’ Opioid Production for 2017 Amid Painkiller Epidemic
The Drug Enforcement Administration (DEA) has announced that it is forcing Big Pharma to reduce 25 percent or more of its manufacturing of ...